Soleus Capital Management’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
Other funds holding PCSA
SFCM
Soleus Capital Management's PCSA Position: Q3 2026 in Review
Soleus Capital Management opened a new position in Processa Pharmaceuticals (PCSA) in Q3 2026: 160,943 shares worth $264K. The stake represents 0.01% of the portfolio and ranks #88 among its holdings.
18 funds tracked by Wall St. Rank hold PCSA as of Q3 2026.
- Soleus Capital Management held 160,943 shares of Processa Pharmaceuticals worth $264K as of Q3 2026.
- Processa Pharmaceuticals was a new Soleus Capital Management position in Q3 2026.
- Processa Pharmaceuticals made up 0.01% of Soleus Capital Management's portfolio in Q3 2026, its #88 holding.
- 18 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q3 2026.
Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.